Hsbc Holdings »

Entrada Therapeutics shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $117k 21k 5.68

More positions owned by Hsbc Holdings

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)
Oracle Corporation (ORCL)

View all positions for Hsbc Holdings

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
MPM Asset Management
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
State Street Corporation
Jacobs Levy Equity Management
Citadel Advisors
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics